Fig. 2From: Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trialTwenty-eight-day all-cause mortality outcomes. mMITT, microbiologically modified intention-to-treat; MITT, modified intention-to-treat; CR-GNB, carbapenem-resistant gram-negative bacilli. The dotted lines represent the noninferiority margins at ≤ 10%Back to article page